Biblio

Author Title Type [ Year(Asc)]
Filters: Author is Gjærde, Lars Klingen  [Clear All Filters]
2023
Gjærde LKlingen, Peczynski C, Polge E, Kröger N, de Latour RPeffault, Finke J, Holler E, Blaise D, Helbig G, Salmenniemi U, et al. Impact of pre-transplantation depression and anxiety on the outcome of allogeneic hematopoietic stem cell transplantation: a study from the Transplant Complications Working Party of the EBMT. Bone Marrow Transplant. 2023.
Rasmussen KK, Santos QDos, MacPherson CRoss, Zucco AG, Gjærde LKlingen, Ilett EE, Lodding I, Helleberg M, Lundgren JD, Nielsen SD, et al. Metabolic Profiling Early Post-Allogeneic Haematopoietic Cell Transplantation in the Context of CMV Infection. Metabolites. 2023;13(9).
Wegener A, Andersen NSmedegaard, Friis LSmidstrup, Petersen SLykke, Schjødt I, Kornblit B, Sengeløv H, Gjærde LKlingen. Triple-drug GVHD prophylaxis after HLA-matched unrelated donor non-myeloablative allogenic hematopoietic stem cell transplantation. Transplant Cell Ther. 2023.
2022
Neuendorff NRosa, Gagelmann N, Singhal S, Meckstroth S, Thibaud V, Zhao Y, Mir N, Shih Y-Y, Amaro DMC, Roy M, et al. Hypomethylating agent-based therapies in older adults with acute myeloid leukemia - A joint review by the Young International Society of Geriatric Oncology and European Society for Blood and Marrow Transplantation Trainee Committee. J Geriatr Oncol. 2022.
Jeppesen H, Gjærde LKlingen, Lindegaard J, Julian HOlsen, Heegaard S, Sengeløv H. Ocular Chronic Graft-Versus-Host Disease and Its Relation to Other Organ Manifestations and Outcomes After Allogeneic Haematopoietic Cell Transplantation. Transplant Cell Ther. 2022.
Horgan C, Serroukh Y, Gjærde LKlingen, Gagelmann N. Recognising inequalities in haematopoietic stem-cell transplantation and cellular therapy training. Lancet Haematol. 2022.